Sep 22 | Mar 22 | Sep 21 | Mar 21 | Sep 20 | |
---|---|---|---|---|---|
Income Statement | - | ||||
Total Revenue | - | - | - | - | - |
Gross Profit | - | - | - | - | - |
EBIT | - | - | - | - | - |
EBITDA | - | - | - | - | - |
Net Income Common Stockholders | - | - | - | - | - |
Balance Sheet | - | ||||
Cash, Cash Equivalents and Short-Term Investments | $ 220.30M | $ 248.10M | $ 166.00M | $ 184.50M | $ 143.20M |
Total Assets | $ 1.71B | $ 1.76B | $ 1.54B | $ 1.49B | $ 1.47B |
Total Debt | $ 23.40M | $ 22.10M | $ ― | $ 26.70M | $ ― |
Net Debt | $ -196.90M | $ -226.00M | $ ― | $ -157.80M | $ ― |
Total Liabilities | $ 661.90M | $ 713.30M | $ 613.40M | $ 596.90M | $ 544.70M |
Stockholders Equity | $ 1.04B | $ 1.04B | $ 926.80M | $ 889.40M | $ 922.90M |
Cash Flow | - | ||||
Free Cash Flow | - | - | - | - | - |
Operating Cash Flow | - | - | - | - | - |
Investing Cash Flow | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - |